The insulin-like growth factor 1 receptor (IGF-1R) mostly employs in the Ras/MAPK and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathways. IGF-1R also cross-talks with the EGFR pathway. This receptor is overexpressed in different human cancers, such as breast, colorectal, lung, and prostate. mAb with inhibitory effect on IGF-1R signaling are classified in two categories, including mAb against IGF-1R and mAbs against IGF-1R ligands (IGF-1 and IGF-2).
AG1024
From $95
AXL1717
From $90
AZD-3463
From $85
BMS-536924
From $95
BMS-754807
From $90
GSK1838705A
From $90
GSK1904529A
From $130
LDK378
From $80
LDK378 dihydrochloride
From $80
NVP-ADW742
From $100
NVP-AEW541
From $100
NVP-TAE 226
From $95
OSI-906
From $210
PQ401
From $90
XL228
From $100